LONDON, Oct. 5, 2015 /PRNewswire/ -- About pulmonary
hypertension
Pulmonary hypertension is a rare disorder that affects the
pulmonary arteries carrying deoxygenated blood to the lungs from
the heart. The narrowing or blockage of pulmonary arteries will
lead to pulmonary hypertension. Symptoms of the disease do not
occur until the disease becomes severe. Certain causes of pulmonary
hypertension include emphysema, connective tissue disorders, blood
clots in lungs, and sleep apnea. Pulmonary hypertension may
sometimes lead to several chronic illnesses, such as kidney failure
(renal failure), heart failure, aneurysm, heart attack, or, stroke.
Endothelin receptor antagonists, prostacyclin analogs,
phosphodiesterase inhibitors, and sGC stimulators are popular drug
therapeutic classes available for the treatment of pulmonary
hypertension.
Technavio's analysts forecast the global pulmonary hypertension
market to grow at a CAGR of 2.92% over the period 2014-2019.
Covered in this report
The report includes the present scenario and the growth prospects
of the global pulmonary hypertension market for the period
2015-2019. To calculate the market size, the report considers
revenue generated through the sales of various drugs used in the
treatment of pulmonary hypertension.
Technavio's report, Global Pulmonary Hypertension Market 2015-2019,
has been prepared based on an in-depth market analysis with inputs
from industry experts. It covers the market size and forecast as
well as market segmentation and pipeline landscape. The report
includes a discussion of the key vendors operating in this
market.
Key vendors
• Actelion
• Bayer
• GlaxoSmithKline
• United Therapeutics
Other prominent vendors
• Aires Pharmaceuticals
• Arena Pharmaceuticals
• Bial
• DEKA
• Dong-A ST
• Gilead
• Merck
• Northern Therapeutics
• Novartis
• Pfizer
• PhaseBio
Key market driver
• Growing incidence of pulmonary hypertension
• For a full, detailed list, view our report
Key market challenge
• Patent expiry
• For a full, detailed list, view our report
Key market trend
• Increased focus on combination therapies
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2019 and what will the growth
rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key
vendors?
• What are the strengths and weaknesses of the key vendors?
Download the full report:
https://www.reportbuyer.com/product/3312135/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that
provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/pulmonary-hypertension---global-market-research-2015-2019-300154535.html
SOURCE ReportBuyer